OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.

Registration to our newsletter is FREE, Join today by entering your email below!

Tag Archives: als

Does BrainStorm Cell Therapeutics (OTCBB: BCLI) Have What it Takes to Halt ALS with Stem Cell Treatment?

Posted on July 17, 2012 by Editor

While BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI) announced on Tuesday their intention to sell 19.8 million shares of their common stock at 29 cents each, effectively raising an estimated $4.78 million, investors found little reason to ignite a buying frenzy … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , | Leave a comment

As Power3 Medical Products, Inc. (OTCBB: PWRM) Refocuses Operations on Adult Stem Cell Market Where Does that Leave Shareholders?

Posted on December 19, 2011 by Editor

When shareholders hear that a company is refocusing their efforts the first thought can be one of considerable concern as it typically means the company’s previous efforts are being abandoned, essentially eliminating the focus that led them to invest in … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , | Leave a comment

Adeona Pharmaceuticals (AMEX: AEN) Advancing Impressive Pipeline of Drug Product Candidates for the Treatment of Progressive Illnesses

Posted on December 12, 2011 by Editor

Shares of Adeona Pharmaceuticals (AMEX: AEN) continue to climb, hitting a six-month high of 1.47 on Monday with trading volume remaining strong as the biotechnology company advances their impressive pipeline of various treatments for serious illnesses. Less than a month … Continue reading →

Posted in AMEX, Articles, Penny Stocks | Tagged , , , , , , , , , , | Leave a comment

BrainStorm Cell Therapeutics (OTCBB: BCLI) Share Price and Volume Jump on Research Analyst Report Despite Absence of Revenue and Products

Posted on June 24, 2011 by Editor

Take a company like BrainStorm Cell Therapeutics (OTCBB: BCLI), which has been trading around the 0.25 – 0.30 with minimal volume over the past several months, throw in a “Buy” recommendation from a research analyst that predicts share price to … Continue reading →

Posted in Articles, OTC Bulletin Board, Penny Stocks | Tagged , , , , , , , , , , , | Leave a comment

With FDA Approval Now Secure What Path Will Avanir Pharmaceuticals Travel?

Posted on November 11, 2010 by Editor

Four years ago Avanir Pharmaceuticals (NASDAQ: AVNR) had to swallow the bitter pill of rejection as the FDA turned down their application for Neudexta due to concerns over heart rhythm safety, as shares tumbled south many questioned whether the pharmaceutical … Continue reading →

Posted in Articles, NASDAQ | Tagged , , , , , , , , , , | Leave a comment